Contract 36F79718D0413
Currax Pharmaceuticals Llc · Department Of Veterans Affairs · March 30, 2018
Currax Pharmaceuticals Llc was awarded a federal contract by Department Of Veterans Affairs on March 30, 2018 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 29 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 3, 2023. If all options are exercised, the contract could reach $17.64 million.
Contract details
- PIID
- 36F79718D0413
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 30, 2018
- Latest action
- October 3, 2023
Description
VENDOR VOLUNTARY CANCELLATION
Modification timeline
-
October 3, 2023Mod P00029$0
-
May 9, 2023Mod P00028POC UPDATES$0
-
April 6, 2023Mod P00027SA & POC UPATES$0
-
December 30, 2022Mod P00026EPA$0
-
November 30, 2022Mod P00025PL 2023$0
-
November 21, 2022Mod P00024TEMP EXT$0
-
December 9, 2021Mod P00023PL 2022$0
-
August 24, 2021Mod P00022ADD$0
-
August 5, 2021Mod P00021ADMIN$0
-
August 4, 2021Mod P00020EPA$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79718D0413?
Contract 36F79718D0413 is a federal contract awarded to Currax Pharmaceuticals Llc by Department Of Veterans Affairs on March 30, 2018 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 29 times since the base award.
Who won contract 36F79718D0413?
Currax Pharmaceuticals Llc won contract 36F79718D0413 from Department Of Veterans Affairs.
How much is contract 36F79718D0413 worth?
Contract 36F79718D0413 has obligated $0 to date but carries a potential ceiling of $17.64 million if fully funded and all options are exercised.